Potential Effects of Bioactive Compounds of Plant-Based Foods and Medicinal Plants in Chronic Kidney Disease and Dialysis: A Systematic Review

Overview

Journal Nutrients

Date 2025 Jan 8

PMID 39770942

Authors

Esmeralda Josa

Guillermina Barril

Mar Ruperto

Affiliations

Soon will be listed here.

Abstract

Background: The bioactive components of plant foods and medicinal plants have attracted interest due to their potential impact on the progression of chronic kidney disease (CKD) and outcomes.

Objective: This study aimed to conduct a critical and quantitative systematic review of randomized clinical trials (RCTs) investigating the potential effects of selected phytochemicals from plant-based foods and medicinal plants in CKD and dialysis patients.

Methods: The review included studies that related plant-based bioactive compounds (curcumin, propolis, sulforaphane, betalain, catechins, rhein, emodin, aloe-emodin, flavonoids, and triptolide) and medicinal plants (green tea, rhubarb, , and Hook F) in CKD and dialysis patients. A literature search was conducted in PubMed, LILACS, Embase, Scopus, and WOS between December 2022 and October 2024. This review was performed according to the PRISMA flowchart and was registered in PROSPERO (595162).

Results: In the eight RCTs conducted with curcumin, anti-inflammatory, antioxidant, and microbiota-modulating properties were reported. As for propolis, in three RCTs, anti-inflammatory, anti-proteinuric, and renal-protective properties were reported. Sulforaphane in one RCT showed antioxidant and cardiovascular benefits, and in another RCT no effects were observed. In one RCT, genistein was shown to be a potential anti-inflammatory agent and improved nutritional status. Allicin in two RCTs showed cardioprotective, antioxidant, anti-inflammatory, and lipid-lowering effects. Finally, beetroot showed a vasodilator effect in one RCT. As for the medicinal plants, green tea, rhubarb, , and Hook F, in six RCTs they showed antioxidant, anti-inflammatory, cardioprotective, antiproteinuric, and renoprotective properties.

Conclusions: These results suggest that bioactive compounds of plant-based foods and medicinal plants have promising effects in terms of preventing or treating CKD progression and appear to improve inflammation and antioxidant capacity and support cardiovascular benefits and renoprotective effects; however, it is recommended that further studies be carried out.

References

Jadad A, Moore R, Carroll D, Jenkinson C, Reynolds D, Gavaghan D . Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials. 1996; 17(1):1-12. DOI: 10.1016/0197-2456(95)00134-4. View

Chermut T, Fonseca L, Figueiredo N, Leal V, Borges N, Cardozo L . Effects of propolis on inflammation markers in patients undergoing hemodialysis: A randomized, double-blind controlled clinical trial. Complement Ther Clin Pract. 2023; 51:101732. DOI: 10.1016/j.ctcp.2023.101732. View

Alvarenga L, Salarolli R, Cardozo L, Santos R, de Brito J, Kemp J . Impact of curcumin supplementation on expression of inflammatory transcription factors in hemodialysis patients: A pilot randomized, double-blind, controlled study. Clin Nutr. 2020; 39(12):3594-3600. DOI: 10.1016/j.clnu.2020.03.007. View

Fu J, Wang Z, Huang L, Zheng S, Wang D, Chen S . Review of the botanical characteristics, phytochemistry, and pharmacology of Astragalus membranaceus (Huangqi). Phytother Res. 2014; 28(9):1275-83. DOI: 10.1002/ptr.5188. View

Kanlaya R, Thongboonkerd V . Molecular Mechanisms of Epigallocatechin-3-Gallate for Prevention of Chronic Kidney Disease and Renal Fibrosis: Preclinical Evidence. Curr Dev Nutr. 2019; 3(9):nzz101. PMC: 6752729. DOI: 10.1093/cdn/nzz101. View

Samadian F, Dalili N, Poor-Reza Gholi F, Fattah M, Malih N, Nafar M . Evaluation of Curcumin's effect on inflammation in hemodialysis patients. Clin Nutr ESPEN. 2018; 22:19-23. DOI: 10.1016/j.clnesp.2017.09.006. View

Peng Q, Li Y, Shang J, Huang H, Zhang Y, Ding Y . Effects of Genistein on Common Kidney Diseases. Nutrients. 2022; 14(18). PMC: 9506319. DOI: 10.3390/nu14183768. View

Foreman K, Marquez N, Dolgert A, Fukutaki K, Fullman N, McGaughey M . Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories. Lancet. 2018; 392(10159):2052-2090. PMC: 6227505. DOI: 10.1016/S0140-6736(18)31694-5. View

Anvarifard P, Ostadrahimi A, Ardalan M, Anbari M, Ghoreishi Z . The effects of propolis on pro-oxidant-antioxidant balance, glycemic control, and quality of life in chronic kidney disease: a randomized, double-blind, placebo-controlled trial. Sci Rep. 2023; 13(1):9884. PMC: 10279753. DOI: 10.1038/s41598-023-37033-z. View

10.

Gantenbein K, Kanaka-Gantenbein C . Mediterranean Diet as an Antioxidant: The Impact on Metabolic Health and Overall Wellbeing. Nutrients. 2021; 13(6). PMC: 8227318. DOI: 10.3390/nu13061951. View

11.

Soroka N, Silverberg D, Greemland M, Birk Y, Blum M, Peer G . Comparison of a vegetable-based (soya) and an animal-based low-protein diet in predialysis chronic renal failure patients. Nephron. 1998; 79(2):173-80. DOI: 10.1159/000045021. View

12.

Rapa S, Di Iorio B, Campiglia P, Heidland A, Marzocco S . Inflammation and Oxidative Stress in Chronic Kidney Disease-Potential Therapeutic Role of Minerals, Vitamins and Plant-Derived Metabolites. Int J Mol Sci. 2020; 21(1). PMC: 6981831. DOI: 10.3390/ijms21010263. View

13.

Khan M, Kassianos A, Hoy W, Alam A, Healy H, Gobe G . Promoting Plant-Based Therapies for Chronic Kidney Disease. J Evid Based Integr Med. 2022; 27:2515690X221079688. PMC: 8902019. DOI: 10.1177/2515690X221079688. View

14.

Borges N, Barros A, Nakao L, Dolenga C, Fouque D, Mafra D . Protein-Bound Uremic Toxins from Gut Microbiota and Inflammatory Markers in Chronic Kidney Disease. J Ren Nutr. 2016; 26(6):396-400. DOI: 10.1053/j.jrn.2016.07.005. View

15.

Biesalski H, Dragsted L, Elmadfa I, Grossklaus R, Muller M, Schrenk D . Bioactive compounds: definition and assessment of activity. Nutrition. 2009; 25(11-12):1202-5. DOI: 10.1016/j.nut.2009.04.023. View

16.

Song C, Xu Y, Lu Y . Use of Tripterygium wilfordii Hook F for immune-mediated inflammatory diseases: progress and future prospects. J Zhejiang Univ Sci B. 2020; 21(4):280-290. PMC: 7183448. DOI: 10.1631/jzus.B1900607. View

17.

Jankowska M, Cobo G, Lindholm B, Stenvinkel P . Inflammation and Protein-Energy Wasting in the Uremic Milieu. Contrib Nephrol. 2017; 191:58-71. DOI: 10.1159/000479256. View

18.

Ribeiro M, Alvarenga L, Coutinho-Wolino K, Nakao L, Cardozo L, Mafra D . Sulforaphane upregulates the mRNA expression of NRF2 and NQO1 in non-dialysis patients with chronic kidney disease. Free Radic Biol Med. 2024; 221:181-187. DOI: 10.1016/j.freeradbiomed.2024.05.034. View

19.

Rysz J, Franczyk B, Lawinski J, Olszewski R, Cialkowska-Rysz A, Gluba-Brzozka A . The Impact of CKD on Uremic Toxins and Gut Microbiota. Toxins (Basel). 2021; 13(4). PMC: 8067083. DOI: 10.3390/toxins13040252. View

20.

Jimenez-Osorio A, Garcia-Nino W, Gonzalez-Reyes S, Alvarez-Mejia A, Guerra-Leon S, Salazar-Segovia J . The Effect of Dietary Supplementation With Curcumin on Redox Status and Nrf2 Activation in Patients With Nondiabetic or Diabetic Proteinuric Chronic Kidney Disease: A Pilot Study. J Ren Nutr. 2016; 26(4):237-44. DOI: 10.1053/j.jrn.2016.01.013. View